NARA Discovery
Article Details
← Back to Search Results
Journal Article

Basic concepts of mixture toxicity and relevance for risk evaluation and regulation

Denise Bloch; Patrick Diel; Bernd Epe; Michael Hellwig; Alfonso Lampen; Angela Mally; Doris Marko; María A. Villar Fernández; Sabine Guth; Angelika Roth; Rosemarie Marchan; Ahmed Ghallab; Cristina Cadenas; Patrick Nell; Nachiket Vartak; Christoph van Thriel; Andreas Luch; Sebastian Schmeisser; Matthias Herzler; Robert Landsiedel; Marcel Leist; Philip Marx-Stoelting; Tewes Tralau; Jan G. Hengstler
Archives of Toxicology · Vol. 97, Issue 11 · pp. 3005-3017 · 2023

Abstract

Exposure to multiple substances is a challenge for risk evaluation. Currently, there is an ongoing debate if generic “mixture assessment/allocation factors” (MAF) should be introduced to increase public health protection. Here, we explore concepts of mixture toxicity and the potential influence of mixture regulation concepts for human health protection. Based on this analysis, we provide recommendations for research and risk assessment. One of the concepts of mixture toxicity is additivity. Substances may act additively by affecting the same molecular mechanism within a common target cell, for example, dioxin-like substances. In a second concept, an “enhancer substance” may act by increasing the target site concentration and aggravating the adverse effect of a “driver substance”. For both concepts, adequate risk management of individual substances can reliably prevent adverse effects to humans. Furthermore, we discuss the hypothesis that the large number of substances to which humans are exposed at very low and individually safe doses may interact to cause adverse effects. This commentary identifies knowledge gaps, such as the lack of a comprehensive overview of substances regulated under different silos, including food, environmentally and occupationally relevant substances, the absence of reliable human exposure data and the missing accessibility of ratios of current human exposure to threshold values, which are considered safe for individual substances. Moreover, a comprehensive overview of the molecular mechanisms and most susceptible target cells is required. We conclude that, currently, there is no scientific evidence supporting the need for a generic MAF. Rather, we recommend taking more specific measures, which focus on compounds with relatively small ratios between human exposure and doses, at which adverse effects can be expected.

Bibliographic Information

JournalArchives of Toxicology
PublisherSpringer
Publication Date2023-11-01
Publication Year2023
Volume97
Issue11
Pages3005-3017
Document TypeJournal Article
Print ISSN0340-5761
eISSN1432-0738
DOI10.1007/s00204-023-03565-6

Access Information

NARA Access Coverage1930-01-01~Current
Journal Homepagehttps://www.springer.com/journal/204
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.